Expansion of prescription criteria for the newest anticoagulant drugs in the NHS

The goal is to better serve the beneficiaries

thumb 800 0 0 0 auto

In order to better serve the beneficiaries, the Health Insurance Organization wishes to inform the beneficiaries that the prescribing criteria for the following medicinal products has been extended:

  1. xarelto
  2. eliquis
  3. Pradaxa

Therefore, a larger number of beneficiaries will be able to receive the above medicinal products through GESS.

Beneficiaries affected by this decision are kindly requested to contact their treating physician in order to be informed whether they meet the new criteria that have entered into force by the Organization.